David Amthelm
Analyst, Piper Sandler
Replay available
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lezek Zuleski
Analyst, Truist Securities
Tony Daimio
Head of Investor Relations
Shintzu Patel
Co‐Founder and Co‐CEO
Chirag Patel
Co‐Founder and Co‐CEO
Tasos Ponideros
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amneal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.255 Good morning, and welcome to the AMNEW Pharmaceuticals 00:00:05.358 -- 00:00:10.784 Third Quarter 2025 Earnings Call. I will now turn the call over to 00:00:10.784 -- 00:00:14.509 AMNEW's Head of Investor Relations, Tony Daimio. 00:00:14.509 -- 00:00:16.969 Please go ahead. 00:00:17.933 -- 00:00:23.340 Good morning, and thank you for joining AMNEW Pharmaceuticals Third Quarter 2025 Earnings 00:00:23.340 -- 00:00:28.145 Call. Today, we issued a press release reporting Q3 results. 00:00:28.145 -- 00:00:32.912 The earnings press release and presentation are available at amneal.com. 00:00:32.912 -- 00:00:37.418 Certain statements made on this call regarding matters that are not historical facts, 00:00:37.418 -- 00:00:42.124 including but not limited to management's outlook or predictions, are forward-looking 00:00:42.124 -- 00:00:47.592 statements that are based solely on information that is now available to us. 00:00:47.592 -- 00:00:52.539 Please see the section entitled Cautionary Statements on Forward-Looking Statements for 00:00:52.539 -- 00:00:55.963 Factors that May Impact Future Performance. 00:00:55.963 -- 00:01:01.199 We also discuss non-GAAP measures. Information on use of these measures in reconciliation 00:01:01.199 -- 00:01:05.125 to GAAP are in the earnings release and presentation. 00:01:05.125 -- 00:01:10.454 On the call today are Chirag and Shintzu Patel, co-founders and co-CEOs, Tasos 00:01:10.454 -- 00:01:15.742 Ponideros CFO, our commercial leaders, Andy Boyer for affordable medicines, 00:01:15.742 -- 00:01:20.069 and Joe Renda for specialty. I will now hand the call over to Chirag. 00:01:20.069 -- 00:01:25.096 Thank you, Tony. Good morning, everyone. We are pleased with our 00:01:25.096 -- 00:01:27.697 strong third...